针对抗生素耐药性的药物组合
Bence Bognár1,2, Réka Spohn2, Viktória Lázár3,4
1HCEMM-BRC Pharmacodynamic Drug Interaction Research Group, Szeged, Hungary.
npj antimicrobials and resistance
|January 22, 2025
概括
药物组合提供了一种有前途的策略,以打击抗生素耐药性的上升,这是一个重大的全球健康威胁. 研究人员正在探索如何结合药物可以克服抵抗机制,并导致新的治疗应用.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 抗生素耐药性是一个日益严重的全球健康危机.
- 新型抗生素开发的管道已经显著减少.
- 药物组合疗法正在成为应对这一挑战的关键策略.
研究的目的:
- 审查药物组合在打击抗生素耐药性的潜力.
- 探索药物相互作用如何利用抗生素耐药性的有害影响.
- 确定各种药物组合的潜在治疗应用.
主要方法:
- 对抗生素耐药性和药物组合现有研究的文献综述.
- 分析药物组合可以克服耐药性的机制.
- 评估不同类型药物相互作用的治疗潜力.
主要成果:
- 药物组合可以有效地抵消抗生素耐药机制.
- 利用抗性的类效应是一种可行的策略.
- 每一种药物相互作用都具有独特的治疗可能性.
结论:
- 合理的药物组合设计对于未来的抗生素疗法至关重要.
- 药物组合在治疗耐药感染方面具有显著的前景.
- 对特定药物相互作用的进一步研究可以打开新的治疗途径.
相关概念视频
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Antibiotic Selection
52.2K
Overview
52.2K
Combined Effects of Drugs: Antagonism
8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


